Short-course antenatal zidovudine reduces both cervicovaginal human immunodeficiency virus type 1 RNA levels and risk of perinatal transmission. Bangkok Collaborative Perinatal HIV Transmission Study Group (Q45745484)
Jump to navigation
Jump to search
scientific article published in January 2000
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Short-course antenatal zidovudine reduces both cervicovaginal human immunodeficiency virus type 1 RNA levels and risk of perinatal transmission. Bangkok Collaborative Perinatal HIV Transmission Study Group |
scientific article published in January 2000 |
Statements
1 reference
Short-course antenatal zidovudine reduces both cervicovaginal human immunodeficiency virus type 1 RNA levels and risk of perinatal transmission. Bangkok Collaborative Perinatal HIV Transmission Study Group (English)
1 reference
Chuachoowong R
1 reference
Shaffer N
1 reference
Siriwasin W
1 reference
Chaisilwattana P
1 reference
Young NL
1 reference
Mock PA
1 reference
Chearskul S
1 reference
Waranawat N
1 reference
Chaowanachan T
1 reference
Karon J
1 reference
Simonds RJ
1 reference
Mastro TD
1 reference
1 January 2000
1 reference
1 reference
181
1 reference
1
1 reference
99-106
1 reference
Identifiers
1 reference
1 reference